📣 VC round data is live. Check it out!
- Public Comps
- Acesis Holdings
Acesis Holdings Valuation Multiples
Discover revenue and EBITDA valuation multiples for Acesis Holdings and similar public comparables like IDEXX Laboratories, Roper Technologies, GE HealthCare, IQVIA and more.
Acesis Holdings Overview
About Acesis Holdings
Acesis Holdings Corp is a holding company and operates through its subsidiaries, which is a research and development company within the life sciences and biotech sector, focusing on the research and development of novel treatments for low testosterone levels in males.
Founded
2022
HQ

Employees
N/A
Website
Financials (FY)
Market Cap
—
Valuation Multiples
Start free trialAcesis Holdings Stock Performance
Acesis Holdings has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAcesis Holdings Valuation Multiples
Acesis Holdings Financial Valuation Multiples
As of May 15, 2026, Acesis Holdings has market cap of —.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Acesis Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Acesis Holdings Competitors
Acesis Holdings competitors include IDEXX Laboratories, Roper Technologies, GE HealthCare, IQVIA, Veeva, United Imaging, Pro Medicus, ICON plc, Glaukos and M3 Inc..
Most Acesis Holdings public comparables operate across Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 10.0x | 9.6x | 28.5x | 27.3x | |||
| 5.3x | 5.2x | 13.3x | 13.1x | |||
| 1.8x | 1.7x | 9.7x | 9.9x | |||
| 2.6x | 2.5x | 11.2x | 11.0x | |||
| 6.0x | 5.8x | 13.1x | 12.7x | |||
| 6.2x | 5.8x | 33.4x | 33.4x | |||
| 58.6x | 49.3x | 75.7x | 55.0x | |||
| 1.4x | 1.5x | 7.7x | 8.1x | |||
This data is available for Pro users. Sign up to see all Acesis Holdings competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Acesis Holdings
| When was Acesis Holdings founded? | Acesis Holdings was founded in 2022. |
| Where is Acesis Holdings headquartered? | Acesis Holdings is headquartered in United States. |
| Is Acesis Holdings publicly listed? | Yes, Acesis Holdings is a public company listed on Nasdaq. |
| What is the stock symbol of Acesis Holdings? | Acesis Holdings trades under ACSB ticker. |
| When did Acesis Holdings go public? | Acesis Holdings went public in 2050. |
| Who are competitors of Acesis Holdings? | Acesis Holdings main competitors include IDEXX Laboratories, Roper Technologies, GE HealthCare, IQVIA, Veeva, United Imaging, Pro Medicus, ICON plc, Glaukos, M3 Inc.. |
| Is Acesis Holdings profitable? | No, Acesis Holdings is not profitable. |
| How many companies Acesis Holdings has acquired to date? | Acesis Holdings hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Acesis Holdings has invested to date? | Acesis Holdings hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Acesis Holdings
Lists including Acesis Holdings
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.